3io Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

3io Therapeutics General Information

Description

Operator of a biotechnology company intended for the development and commercialization of the next generation of viral immunotherapies for cancer. The company engages in developing novel viral immunotherapy based on bovine herpesvirus type for hard-to-treat cancers and helps boost checkpoint inhibitor efficacy, immuno-stimulating mechanism of action, monotherapy with minimal genetic engineering, anti-tumor efficacy, enabling clients to improve treatment responses and outcomes for cancers including those with KRAS-mutations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • First Canadian Place, 100 King Street West
  • Suite 5700
  • Toronto, Ontario M5X 1C7
  • Canada
+1 (339)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • First Canadian Place, 100 King Street West
  • Suite 5700
  • Toronto, Ontario M5X 1C7
  • Canada
+1 (339)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

3io Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Dec-2025 Completed Generating Revenue
1. Accelerator/Incubator 28-Jul-2022 Completed Generating Revenue
To view 3io Therapeutics’s complete valuation and funding history, request access »

3io Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

3io Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novatio Ventures Venture Capital Minority
Innovation Factory (Hamilton) Accelerator/Incubator
To view 3io Therapeutics’s complete investors history, request access »

3io Therapeutics FAQs

  • When was 3io Therapeutics founded?

    3io Therapeutics was founded in 2020.

  • Where is 3io Therapeutics headquartered?

    3io Therapeutics is headquartered in Toronto, Canada.

  • What is the size of 3io Therapeutics?

    3io Therapeutics has 3 total employees.

  • What industry is 3io Therapeutics in?

    3io Therapeutics’s primary industry is Drug Discovery.

  • Is 3io Therapeutics a private or public company?

    3io Therapeutics is a Private company.

  • What is 3io Therapeutics’s current revenue?

    The current revenue for 3io Therapeutics is .

  • Who are 3io Therapeutics’s investors?

    Novatio Ventures and Innovation Factory (Hamilton) have invested in 3io Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process